{
  "retracted": false,
  "timestamp": 1247616000000,
  "updates": [
    {
      "timestamp": 1586835614926,
      "identifier": {
        "doi": "10.1038/leu.2009.115"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/leu.2009.77"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells"
}
